Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in Italy.
Giossi R, Consonni A, Torri Clerici V, Zito A, Rigoni E, Antozzi C, Brambilla L, Crisafulli SG, Bellino A, Frangiamore R, Bonanno S, Vanoli F, Ciusani E, Corsini E, Andreetta F, Baggi F, Tramacere I, Mantegazza R, Conte A, Bergamaschi R, Confalonieri P. Giossi R, et al. Among authors: tramacere i. Mult Scler Relat Disord. 2022 Feb;58:103415. doi: 10.1016/j.msard.2021.103415. Epub 2021 Nov 22. Mult Scler Relat Disord. 2022. PMID: 35216790 Free PMC article.
Quantitative Muscle MRI Protocol as Possible Biomarker in Becker Muscular Dystrophy.
Maggi L, Moscatelli M, Frangiamore R, Mazzi F, Verri M, De Luca A, Pasanisi MB, Baranello G, Tramacere I, Chiapparini L, Bruzzone MG, Mantegazza R, Aquino D. Maggi L, et al. Among authors: tramacere i. Clin Neuroradiol. 2021 Mar;31(1):257-266. doi: 10.1007/s00062-019-00875-0. Epub 2020 Jan 23. Clin Neuroradiol. 2021. PMID: 31974637
A resilience group training program for people with multiple sclerosis: Results of a pilot single-blind randomized controlled trial and nested qualitative study.
Giovannetti AM, Quintas R, Tramacere I, Giordano A, Confalonieri P, Messmer Uccelli M, Solari A, Pakenham KI. Giovannetti AM, et al. Among authors: tramacere i. PLoS One. 2020 Apr 9;15(4):e0231380. doi: 10.1371/journal.pone.0231380. eCollection 2020. PLoS One. 2020. PMID: 32271833 Free PMC article. Clinical Trial.
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3.
Maggi L, Bello L, Bonanno S, Govoni A, Caponnetto C, Passamano L, Grandis M, Trojsi F, Cerri F, Ferraro M, Bozzoni V, Caumo L, Piras R, Tanel R, Saccani E, Meneri M, Vacchiano V, Ricci G, Soraru' G, D'Errico E, Tramacere I, Bortolani S, Pavesi G, Zanin R, Silvestrini M, Politano L, Schenone A, Previtali SC, Berardinelli A, Turri M, Verriello L, Coccia M, Mantegazza R, Liguori R, Filosto M, Marrosu G, Siciliano G, Simone IL, Mongini T, Comi G, Pegoraro E. Maggi L, et al. Among authors: tramacere i. J Neurol Neurosurg Psychiatry. 2020 Nov;91(11):1166-1174. doi: 10.1136/jnnp-2020-323822. Epub 2020 Sep 11. J Neurol Neurosurg Psychiatry. 2020. PMID: 32917822
Quality of life assessment in adult spinal muscular atrophy patients treated with nusinersen.
Bonanno S, Zanin R, Bello L, Tramacere I, Bozzoni V, Caumo L, Ferraro M, Bortolani S, Sorarù G, Silvestrini M, Vacchiano V, Turri M, Tanel R, Liguori R, Coccia M, Mantegazza RE, Mongini T, Pegoraro E, Maggi L. Bonanno S, et al. Among authors: tramacere i. J Neurol. 2022 Jun;269(6):3264-3275. doi: 10.1007/s00415-021-10954-3. Epub 2022 Jan 3. J Neurol. 2022. PMID: 34978620
124 results